Ghost Tree Capital, LLC quarter change: USA Stocks, Sold out
In share positions in stocks (listed in the US), from the quarter ended 2024-06-30 to 2024-09-30, Ghost Tree Capital, LLC opened 8 positions, added to 15, reduced 20, sold out of 14 and left 2 unchanged. The largest increase in value was JANX (+$6,537,200); the largest decrease was BHVN (-$17,007,900).
- BHVN: Country of operation United States; Class COM; Shares 2024-06-30 490,000; Shares 2024-09-30 0.
- ALNY: Country of operation United States; Class COM; Shares 2024-06-30 22,500; Shares 2024-09-30 0.
- ACAD: Country of operation United States; Class COM; Shares 2024-06-30 225,000; Shares 2024-09-30 0.
- CABA: Country of operation United States; Class COM; Shares 2024-06-30 370,899; Shares 2024-09-30 0.
Two Form 13F-HR filings compared (SEC CIK 1595851): 2024-06-30 (filed 2024-08-14) and 2024-09-30 (filed 2024-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
| Stock | Country of operation | Class | Shares 2024-06-30 | Shares 2024-09-30 | Share change | Value 2024-06-30 | Value 2024-09-30 | Value change |
|---|
BHVN
BIOHAVEN LTD | United States | COM | 490,000 | 0 | -490,000 | $17,007,900 | $0 | -$17,007,900 |
|---|
ALNY
ALNYLAM PHARMACEUTICALS INC | United States | COM | 22,500 | 0 | -22,500 | $5,467,500 | $0 | -$5,467,500 |
|---|
ACAD
ACADIA PHARMACEUTICALS INC | United States | COM | 225,000 | 0 | -225,000 | $3,656,250 | $0 | -$3,656,250 |
|---|
CABA
CABALETTA BIO INC | United States | COM | 370,899 | 0 | -370,899 | $2,774,325 | $0 | -$2,774,325 |
|---|
CYTK
CYTOKINETICS INC | United States | COM NEW | 33,200 | 0 | -33,200 | $1,798,776 | $0 | -$1,798,776 |
|---|
KRYS
KRYSTAL BIOTECH INC | United States | COM | 8,500 | 0 | -8,500 | $1,560,940 | $0 | -$1,560,940 |
|---|
ARWR
ARROWHEAD PHARMACEUTICALS IN | United States | COM | 35,000 | 0 | -35,000 | $909,650 | $0 | -$909,650 |
|---|
SGMT
SAGIMET BIOSCIENCES INC | United States | COM SER A | 225,000 | 0 | -225,000 | $769,500 | $0 | -$769,500 |
|---|
MGNX
MACROGENICS INC | United States | COM | 150,000 | 0 | -150,000 | $637,500 | $0 | -$637,500 |
|---|
PMVP
PMV PHARMACEUTICALS INC | United States | COM | 375,000 | 0 | -375,000 | $607,500 | $0 | -$607,500 |
|---|
PTCT
PTC THERAPEUTICS INC | United States | COM | 19,000 | 0 | -19,000 | $581,020 | $0 | -$581,020 |
|---|
NTLA
INTELLIA THERAPEUTICS INC | United States | COM | 25,000 | 0 | -25,000 | $559,500 | $0 | -$559,500 |
|---|
ANTX
AN2 THERAPEUTICS INC | United States | COM | 219,331 | 0 | -219,331 | $471,562 | $0 | -$471,562 |
|---|
CTMX
CYTOMX THERAPEUTICS INC | United States | COM | 300,000 | 0 | -300,000 | $366,000 | $0 | -$366,000 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |